Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Patricia Gavín-Benavent"'
Autor:
María José Vicente-Edo, Yolanda Triñanes, Ana Toledo-Chávarri, María Bono-Vega, Patricia Gavín-Benavent, Lucía Prieto-Remón, Begoña Suñe, Margarita Segovia, Blanca Novella-Arribas, Loeches-Belinchón Pilar, Paula Cantero-Muñoz, Lilisbeth Perestelo-Pérez, Nerea Arias Jayo, Eva Reviriego-Rodrigo
Publikováno v:
International Journal of Technology Assessment in Health Care. 38:S83-S83
IntroductionPatients have knowledge, perspectives and experiences that are unique and can make an essential contribution to Health Technology Assessment (HTA). However, in order for their participation to be effective, they need to be able to underst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96502f44e7f271bb84d23c6d5f495c7e
https://doi.org/10.1017/s0266462322002495
https://doi.org/10.1017/s0266462322002495
Autor:
Patricia Gavín Benavent, Juan Máximo Molina Linde, Elisa Puigdomènech, Ana Toledo-Chávarri, Yolanda Triñanes Pego, Nora Ibargoyen Roteta, Maria Jose Vicente Edo, Eva Reviriego Rodrigo, Blanca Novella-Arribas
Publikováno v:
International journal of technology assessment in health care. 37
Objective The Spanish Network of Agencies for Assessing National Health System Technologies and Performance (RedETS) defined a patient involvement (PI) framework for health technology assessment (HTA) activities in 2016. The aim of this study is to e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0d761375660a5f723611cdc2ad1ff4f
https://pubmed.ncbi.nlm.nih.gov/32914735
https://pubmed.ncbi.nlm.nih.gov/32914735
Autor:
Isabel Pujol Bajador, MARIA LECUONA, María José Iglesias Gozalo, Jaime Esteban Moreno, Rosario Cogollos, Patricia Gavín Benavent, Sofia Samper, Natalia Montiel Quezel-Guerraz, Juan-José Palacios-Gutiérrez, EVA CUCHÍ BURGOS, RAMIRO LÓPEZ-MEDRANO, Carlos Martin
Publikováno v:
Infection, Genetics and Evolution. 12:701-710
The data presented here span 11 years (1998-2008) of monitoring of multidrug-resistant tuberculosis (MDR-TB) clustering through molecular typing techniques in Spain. The molecular and epidemiological data of 480 multidrug-resistant Mycobacterium tube
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1cabdf3a084cf97730dfe592ceda1e4
https://doi.org/10.1016/j.meegid.2011.05.016
https://doi.org/10.1016/j.meegid.2011.05.016
Autor:
Toledo-Chávarri, Ana, Triñanes Pego, Yolanda, Rodrigo, Eva Reviriego, Roteta, Nora Ibargoyen, Novella-Arribas, Blanca, Vicente Edo, María José, Gavín Benavent, Patricia, Puigdomenech, Elisa, Molina Linde, Juan Máximo
Publikováno v:
International Journal of Technology Assessment in Health Care; 2021, Vol. 37 Issue 1, p1-6, 6p
Publikováno v:
International Journal of Technology Assessment in Health Care; 2022 Supplement 1, Vol. 38, pS82-S83, 2p
Title: Effectiveness and safety of GLP-1 receptor analogues versus rapid-acting insulin added to basal insulin therapy in patients with type 2 diabetes mellitus: A living systematic review. Authors: María Soledad Isern de Val ORCID: https://orcid.or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11385248a7ee3485c290965e5f861de3
Autor:
Vicente-Edo, María José, Triñanes, Yolanda, Toledo-Chávarri, Ana, Bono-Vega, María, Gavín-Benavent, Patricia, Prieto-Remón, Lucía, Suñe, Begoña, Segovia, Margarita, Novella-Arribas, Blanca, Pilar, Loeches-Belinchón, Cantero-Muñoz, Paula, Perestelo-Pérez, Lilisbeth, Jayo, Nerea Arias, Reviriego-Rodrigo, Eva
Publikováno v:
International Journal of Technology Assessment in Health Care; 2022 Supplement 1, Vol. 38, pS83-S83, 1p
Autor:
Ramallo-Fariña, Yolanda, González-Pacheco, Himar, Sacks, Analía Abt, García-Hernández, Laura, de Segura, Ignacio Llorente-Gomez, Wägner, Ana, Toledo-Chávarri, Ana, Serrano-Aguilar, Pedro
Publikováno v:
International Journal of Technology Assessment in Health Care; 2022 Supplement 1, Vol. 38, pS83-S83, 1p
Autor:
Jen Tidman, Wout Feitz
Rare and Complex Urology combines information on clinical aspects, network developments and patient journeys in specific rare and complex urological diseases within the ERN (European Reference Network) template structure, allowing for better diagnosi